Home > Chapters
Chapters
-
Part I: Antibiotic resistance - Local scenario
- 1.1 Background: the problem of antimicrobial resistance (AMR) in Hong Kong (HK)
- 1.2 Methicillin-resistant Staphylococcus aureus (MRSA)
- 1.3 Vancomycin-resistant enterococci (VRE)
- 1.4 ESBL-producing Enterobacteriaceae
- 1.5 Carbapenem-resistant Enterobacteriaceae (CRE)
- 1.6 Carbapenem-resistant Acinetobacter baumannii (CRAB)
- 1.7 Macrolide Resistant Mycoplasma pneumoniae (MRMP)
-
Part II: Antimicrobial stewardship programme
-
Part III: Guidelines for selected antimicrobial use
-
Part IV: Recommendation for the empirical therapy of common infections
-
Part V: Guidelines for known-pathogen therapy
- Acinetobacter baumannii
- Clostridium difficile
- Enterobacter cloacae complex
- E. coli (ESBL-neg)
- Haemophilus influenzae
- Klebsiella pneumoniae (ESBL-neg)
- E. coli/K. pneumoniae (ESBL-pos)
- Pseudomonas aeruginosa
- Methicillin-sensitive S. aureus
- Methicillin-resistant S. aureus
- Mycoplasma pneumoniae
- Stenotrophomonas maltophilia
- Streptococcus pneumoniae (for infection outside the central nervous system)
- Streptococcus pneumoniae (for central nervous system infection)
-
Part VI: Guidelines for surgical prophylaxis
-
Part VII: Cost and recommended dosage of commonly-used antimicrobial agents
-
Part VIII: Other issues
